MyMedR

Displaying all 4 publications

Abstract:

Sort:

Prevalence and description of digital device use among preschool children: A cross-sectional study in Kota Setar District, Kedah

Nathan T, Muthupalaniappen L, Muhammad NA

Malays Fam Physician, 2022 Nov 30;17(3):114-120.
PMID: 36606161 DOI: 10.51866/oa.25

INTRODUCTION: Digital device helps children enhance academic, cognitive and psychomotor skills. However, prolonged use causes physical inactivity, poor interpersonal skills and communication problems. Information on digital device use among young children in Malaysia is currently limited. Hence, this study aimed to determine the prevalence of digital device utilisation among preschool children in Kota Setar District, Kedah.
METHOD: A cross-sectional study at government preschools in Kota Setar District was conducted from February to April 2020. Selection of preschools and students was done using multistage simple randomisation. A self-administered questionnaire containing demographic and digital device use details was filled by parents.
RESULTS: The prevalence of digital device use among preschool children was 95.9% and mostly used smartphones (94.2%). Most children (95%) did not own the device, and usage was under supervision (95.7%). The reason for supervision was to prevent exposure to inappropriate content (70.5%). The common reasons for allowing digital device use were for educational (37.4%) and entertainment purposes (36%) through videos (30.9%) and games (30.2%). Approximately 21.5% and 50.3% of the children spent more than 1 and 2 hours on digital devices during weekdays and weekends, respectively.
CONCLUSION: The prevalence of digital device use among the preschool children in Kota Setar District was very high. Most of them used digital devices for educational and entertainment purposes under parental supervision. However, some exceeded the recommended screen time on weekends. These findings could promote awareness of digital device use among young children and help design public health awareness programmes and future policies.
Fulltext Brain-Derived Neurotrophic Factor Polymorphism and Aphasia after Stroke

Lee NT, Ahmedy F, Mohamad Hashim N, Yin KN, Chin KL

Behav Neurol, 2021;2021:8887012.
PMID: 34367374 DOI: 10.1155/2021/8887012

Stroke is one of the most deliberating causes of mortality and disability worldwide. Studies have implicated Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene as a genetic factor influencing stroke recovery. Still, the role of BDNF polymorphism in poststroke aphasia is relatively unclear. This review assesses the recent evidence on the association between the BDNF polymorphism and aphasia recovery in poststroke patients. The article highlights BNDF polymorphism characteristics, speech and language interventions delivered, and the influence of BNDF polymorphism on poststroke aphasia recovery. We conducted a literature search through PubMed and Google Scholar with the following terms: "brain derived-neurotrophic factor" and "aphasia" for original articles from January 2000 until June 2020. Out of 69 search results, a detailed selection process produced a total of 3 articles that met the eligibility criteria. All three studies included Val66Met polymorphism as the studied human BDNF gene. One of the studies demonstrated insufficient evidence to conclude that BDNF polymorphism plays a role in poststroke aphasia recovery. The remaining two studies have shown that Met allele genotype (either single or double nucleotides) was associated with poor aphasia recovery, in either acute or chronic stroke. Carriers of the Val66Met polymorphism of BDNF gave a poorer response to aphasia intervention and presented with more severe aphasia.
Fulltext Cenozoic Rotation History of Borneo and Sundaland, SE Asia Revealed by Paleomagnetism, Seismic Tomography, and Kinematic Reconstruction

Advokaat EL, Marshall NT, Li S, Spakman W, Krijgsman W, van Hinsbergen DJJ

Tectonics, 2018 Aug;37(8):2486-2512.
PMID: 30333679 DOI: 10.1029/2018TC005010

SE Asia comprises a heterogeneous assemblage of fragments derived from Cathaysia (Eurasia) in the north and Gondwana in the south, separated by suture zones representing closed former ocean basins. The western part of the region comprises Sundaland, which was formed by Late Permian-Triassic amalgamation of continental and arc fragments now found in Indochina, the Thai Penisula, Peninsular Malaysia, and Sumatra. On Borneo, the Kuching Zone formed the eastern margin of Sundaland since the Triassic. To the SE of the Kuching Zone, the Gondwana-derived continental fragments of SW Borneo and East Kalimantan accreted in the Cretaceous. South China-derived fragments accreted to north of the Kuching Zone in the Miocene. Deciphering this complex geodynamic history of SE Asia requires restoration of its deformation history, but quantitative constraints are often sparse. Paleomagnetism may provide such constraints. Previous paleomagnetic studies demonstrated that Sundaland and fragments in Borneo underwent vertical axis rotations since the Cretaceous. We provide new paleomagnetic data from Eocene-Miocene sedimentary rocks in the Kutai Basin, east Borneo, and critically reevaluate the published database, omitting sites that do not pass widely used, up-to-date reliability criteria. We use the resulting database to develop an updated kinematic restoration. We test the regional or local nature of paleomagnetic rotations against fits between the restored orientation of the Sunda Trench and seismic tomography images of the associated slabs. Paleomagnetic data and mantle tomography of the Sunda slab indicate that Sundaland did not experience significant vertical axis rotations since the Late Jurassic. Paleomagnetic data show that Borneo underwent a ~35° counterclockwise rotation constrained to the Late Eocene and an additional ~10° counterclockwise rotation since the Early Miocene. How this rotation was accommodated relative to Sundaland is enigmatic but likely involved distributed extension in the West Java Sea between Borneo and Sumatra. This Late Eocene-Early Oligocene rotation is contemporaneous with and may have been driven by a marked change in motion of Australia relative to Eurasia, from eastward to northward, which also has led to the initiation of subduction along the eastern Sunda trench and the proto-South China Sea to the south and north of Borneo, respectively.
Fulltext Placebo effects in randomized trials of pharmacological and neurostimulation interventions for mental disorders: An umbrella review

Huneke NTM, Amin J, Baldwin DS, Bellato A, Brandt V, Chamberlain SR, et al.

Mol Psychiatry, 2024 Dec;29(12):3915-3925.
PMID: 38914807 DOI: 10.1038/s41380-024-02638-x

There is a growing literature exploring the placebo response within specific mental disorders, but no overarching quantitative synthesis of this research has analyzed evidence across mental disorders. We carried out an umbrella review of meta-analyses of randomized controlled trials (RCTs) of biological treatments (pharmacotherapy or neurostimulation) for mental disorders. We explored whether placebo effect size differs across distinct disorders, and the correlates of increased placebo effects. Based on a pre-registered protocol, we searched Medline, PsycInfo, EMBASE, and Web of Knowledge up to 23.10.2022 for systematic reviews and/or meta-analyses reporting placebo effect sizes in psychopharmacological or neurostimulation RCTs. Twenty meta-analyses, summarising 1,691 RCTs involving 261,730 patients, were included. Placebo effect size varied, and was large in alcohol use disorder (g = 0.90, 95% CI [0.70, 1.09]), depression (g = 1.10, 95% CI [1.06, 1.15]), restless legs syndrome (g = 1.41, 95% CI [1.25, 1.56]), and generalized anxiety disorder (d = 1.85, 95% CI [1.61, 2.09]). Placebo effect size was small-to-medium in obsessive-compulsive disorder (d = 0.32, 95% CI [0.22, 0.41]), primary insomnia (g = 0.35, 95% CI [0.28, 0.42]), and schizophrenia spectrum disorders (standardized mean change = 0.33, 95% CI [0.22, 0.44]). Correlates of larger placebo response in multiple mental disorders included later publication year (opposite finding for ADHD), younger age, more trial sites, larger sample size, increased baseline severity, and larger active treatment effect size. Most (18 of 20) meta-analyses were judged 'low' quality as per AMSTAR-2. Placebo effect sizes varied substantially across mental disorders. Future research should explore the sources of this variation. We identified important gaps in the literature, with no eligible systematic reviews/meta-analyses of placebo response in stress-related disorders, eating disorders, behavioural addictions, or bipolar mania.